4.
Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone
threshold for androgen de
f
ciency symptoms.
J Clin Endocrinol
Metab
. 2004;89:3813-3817
.
5.
Zitzmann M, Faber S, Nieschlag E. Association of speci
f
c symptoms
and metabolic risks with serum testosterone in older men.
J Clin
Endocrinol Metab
. 2006;91:4335-4343
.
6.
Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptom-
atic androgen de
f
ciency in men.
J Clin Endocrinol Metab
. 2007;92:
4241-4247
.
7.
Wu FC, Tajar A, Beynon JM, et al. Identi
f
cation of late-onset
hypogonadism in middle-aged and elderly men.
N Engl J Med
.
2010;363:123-135
.
8.
Shea JL, Wongt PY, Chen Y. Free testosterone: clinical utility and
important analytical aspects of measurement.
Adv Clin Chem
. 2014;
63:59-84
.
9.
Cardarelli R, Singh M, Meyer J, et al. The association of free
testosterone levels in men and lifestyle factors and chronic disease
status: a North Texas Healthy Heart Study.
J Prim Care Community
Health
. 2014;5:173-179
.
10.
Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM. Perfor-
mance of total testosterone measurement to predict free testosterone
for the biochemical evaluation of male hypogonadism.
J Urol
. 2012;
187:1369-1373
.
11.
Lackner JE, Rucklinger E, Schatzl G, et al. Are there symptom-
speci
f
c testosterone thresholds in aging men?
BJU Int
. 2011;108:
1310-1315
.
12.
Cabral RD, Busin L, Rosito TE, Koff WJ. Performance of Massa-
chusetts Male Aging Study (MMAS) and androgen de
f
ciency in
the aging male (ADAM) questionnaires in the prediction of free
testosterone in patients aged 40 years or older treated in outpatient
regimen.
Aging Male
. 2014;17:147-154
.
13.
Bernie AM, Scovell JM, Ramasamy R. Comparison of question-
naires used for screening and symptom identi
f
cation in hypo-
gonadal men.
Aging Male
. 2014:1-4
.
290
UROLOGY 86 (2), 2015